Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Brendan Everett MD, MPH

Brendan M. Everett MD, MPH

Director, General Cardiology Inpatient Service, Cardiovascular Division, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School; Investigator, Center for Cardiovascular Disease Prevention, Boston, Massachusetts

Dr. Brendan M. Everett is general and preventive cardiologist at Brigham and Women’s Hospital (BWH) and an Associate Professor of Medicine at Harvard Medical School (HMS). Dr. Everett has a long-standing interest in preventing heart attack, hear failure, stroke, amputation, and death in patients with type 2 diabetes. Together with Dr. Deborah Wexler and Dr. Robert J. Glynn, he is running a large, comparative effectiveness trial in patients with type 2 diabetes and cardiovascular disease or at high risk. This trial, called the PRECIDENTD study, represents the next step to figure out how best to help patients with diabetes live free of heart and vascular disease.

Disclosures

Dr Everett reports research support from Novo Nordisk and PCORI; consulting fees from the American Heart Association, Eli Lilly and Company, Ipsen Pharmaceuticals, Janssen Pharmaceuticals, and Novo Nordisk; and royalties from UpToDate.